Merck's Prinzide
Executive Summary
Lisinopril/hydrochlorothiazide combination approved for hypertension. Merck kicked off the launch of the Prinivil 20 mg/hydrochlorothiazide 12.5 mg combo with a press announcement on Feb. 17. The ACE inhibitor/diuretic combination will compete with Squibb's Capozide and Merck's Vaseretic. ICI also has rights to a lisinopril/hydrochlorothiazide product under the company's co-marketing agreement with Merck covering Zestril.
Lisinopril/hydrochlorothiazide combination approved for
hypertension. Merck kicked off the launch of the Prinivil 20
mg/hydrochlorothiazide 12.5 mg combo with a press announcement on
Feb. 17. The ACE inhibitor/diuretic combination will compete with
Squibb's Capozide and Merck's Vaseretic. ICI also has
rights to a lisinopril/hydrochlorothiazide product under the
company's co-marketing agreement with Merck covering
Zestril.
|